- Single-day highest jump in COVID-19 cases in the country
- 67,000 cases of the novel Coronavirus were recorded
- The total tally of COVID-19 cases in country has crossed 23 lakh
On Thursday, India reported its highest single-day surge in the Coronavirus cases with 66,999 cases and also reported 942 deaths in the past 24 hours as per the figures shared by the Ministry of Health and Family Welfare.
India’s total tally of the Coronavirus cases has touched 23,96,638 which includes 6,53,622 active cases, 16,95,982 recovered cases and 47,033 deaths.
The highest number of active cases in the country are in Maharashtra which stands firm at 1,47,820 which is followed by Andhra Pradesh with 90,425 active cases.
Additionally, the highest samples tested in a single day was also recorded by India at 8,30,391 on the 12th of August. So far a total of 268,45,688 samples have been tested as per the data shared by the Indian Council of Medical Research (ICMR).
India which has the third biggest caseload in the world, behind the United States of America (USA) and Brazil, has reported a jump of 50,000 COVID-19 cases or more every day for 15 days straight.
Currently, the USA stands at the number 1 position in the worst hit country by COVID-19 by both number of cases and number of death at 53,60,302 cases and 1,69,131 deaths.
Brazil is 2nd with 31,70,474 cases and 1,04,263 deaths.
The phone Call Detail Records (CDRs) of the COVID-19 patients were being used by the Kerala Police as a part of adopting innovative and scientific methods for effective contact tracing, the Chief Minister Pinarayi Vijayan said on Wednesday.
Vijayan assured that these details would not be used for any other purpose and there would be no intrusion into the privacy of the patients. “…the state Police chief had given instruction to collect the call detail records (CDRs) of COVID-19 patients.
On Wednesday, the government said that a single central system will be set to gather the Coronavirus vaccines for pan-India. This will be supervised directly by the Central Government and has advised the state governments to not begin a separate process to procure the antigen.